U.S. COVID death toll tops fall peak and is higher than in other wealthy countries, as global deaths climb 9% in latest week

Argentina Noticias Noticias

U.S. COVID death toll tops fall peak and is higher than in other wealthy countries, as global deaths climb 9% in latest week
Argentina Últimas Noticias,Argentina Titulares
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 73 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 97%

Coronavirus Update: U.S. death rate higher than those of other wealthy countries

The average number of daily deaths from COVID-19 in the U.S. over the past week has climbed above 2,600, according to a New York Times tracker, now higher than the peak surge in the fall when the delta variant was the dominant variant and close to the peak last winter, before vaccines were available.

Read: U.S. businesses shed 301,000 jobs in January, ADP says, in biggest drop since start of pandemic as omicron hits The only European countries with higher death rates are Russia, Ukraine, Poland, Greece and the Czech Republic, the Times reported, noting that treatments in those countries are in short supply.

Denmark on Tuesday became the first European Union country to drop all of its COVID restrictions — including face masks, vaccine passes and limited opening hours — even as it is seeing record numbers of cases. Norway followed suit on Wednesday. The U.K. and Ireland have also dropped most restrictions, the former amid a political firestorm over Downing Street parties held during strict national lockdowns.

Tedros Adhanom Ghebreyesus, WHO director-general, noted that omicron has already infected nearly 90 million people since it was first brought to light by researchers in South Africa in November, more COVID-19 cases than were counted in all of 2020. The omicron subvariant, also identified as BA.2, is now in 57 countries, according to the update, which encouraged investigations into its transmissibility, immune escape properties and virulence.• As expected, Pfizer PFE, +0.76% and German partner BioNTech BNTX, -0.86% late Tuesday asked the Food and Drug Administration to authorize the emergency use of their COVID-19 vaccine for children under 5 in the U.S., saying that three doses of the vaccine may be needed.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

MarketWatch /  🏆 3. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Pfizer asks FDA to allow COVID-19 vaccine for kids under 5Pfizer asks FDA to allow COVID-19 vaccine for kids under 5Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
Leer más »

When can children younger than 5 get vaccinated against Covid-19?When can children younger than 5 get vaccinated against Covid-19?Children younger than 5 in the United States could begin receiving Covid-19 vaccinations this month or next if the US Food and Drug Administration moves quickly to authorize the shot for this age group.
Leer más »

COVID-19 live updates: Santa Clara Co. approves extra vaccine dose for immunocompromisedCOVID-19 live updates: Santa Clara Co. approves extra vaccine dose for immunocompromisedTransplant recipients, cancer patients and people with immunodeficiencies can now receive a third dose of the Moderna or Pfizer vaccine in Santa Clara County.
Leer más »

Pfizer asks FDA to allow COVID-19 vaccine for kids under 5Pfizer asks FDA to allow COVID-19 vaccine for kids under 5The move could open the way for the very youngest in the country to start receiving shots as early as March.
Leer más »

Denmark becomes first EU country to lift all Covid-19 restrictionsDenmark becomes first EU country to lift all Covid-19 restrictionsDenmark has lifted all Covid-19 restrictions within the country, with coronavirus no longer considered a 'socially critical sickness,' according to the government.
Leer más »

The COVID-19 Metrics Policymakers Should Be Watching After OmicronThe COVID-19 Metrics Policymakers Should Be Watching After OmicronThe COVID-19 pandemic has brought up tons of data questions — what information should we be collecting, what can it tell us (and what does it fail to tell us) …
Leer más »



Render Time: 2025-04-02 04:31:33